Nanostring Technologies

Develops products that unlock genomic information from tissue and enable scientists and clinicians to create tests to improve patient care. Its first offering in the molecular diagnostics market, the Prosigna Breast Cancer Assay, received EU regulatory clearance last year. The company filed to go public in May 2013.

2013 Inc. 5000 Rank:
# 1783
Leadership:
R. Bradley Gray
Industry:
Health
Location:
Seattle, WA 
Founded:
2003

Previous Inc. 5000 Rankings 

MORE COMPANY INFORMATION